시장보고서

상품코드

1565678

세계의 흉막염 치료 시장 : 진단별, 치료법별, 투여 형태별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Pleurodynia Treatment Market, By Diagnosis, By Treatment, By Mode of Administration, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 09월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 288 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

세계 흉막염 치료제 시장 규모는 2023년 1억 3,090만 달러로 평가되었고, 2024-2032년간 연평균 5.90% 성장할 것으로 예상됩니다.

흉막염 치료제 시장 - 시장 역학

바이러스 감염 증가로 인한 흉막염 발생률 증가

흉막염은 콕사키 바이러스와 같은 바이러스 감염에 의해 발생하는 경우가 많지만, 바이러스 감염 증가로 인해 환자 수가 증가하고 있습니다. 이러한 추세는 흉막염 치료 시장에도 반영되어 더 많은 사례가 진단 및 관리됨에 따라 성장하고 있습니다. 바이러스 감염, 특히 추운 계절에 유행하는 바이러스 감염은 흉막염 발생률 증가에 기여하고 있습니다.

세계보건기구(WHO)는 Global Health Estimates를 통해 관련 데이터를 제공하고 있으며, 2021년 보고서에 따르면 흉막염을 유발하는 바이러스 감염을 포함한 바이러스 감염은 지난 10년간 눈에 띄게 증가했다고 합니다. 특히 흉막염을 포함한 호흡기 증상을 유발하는 바이러스 감염의 발생률은 2010년부터 2020년까지 약 20% 증가했습니다. 이러한 사례 증가는 효과적인 치료 및 개입에 대한 수요 증가를 강조하고 흉막염 치료 시장의 성장을 가속하고 있습니다.

흉막염 치료 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 연평균 약 5.90%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 추정됩니다.

진단별로는 혈액 검사가 2023년에 가장 높은 시장 점유율을 보였습니다.

치료법별로는 진통제와 진통제가 2023년 주요 유형으로 나타났습니다.

투여 형태별로는 경구용 의약품이 2023년 주요 유형으로 나타났습니다.

지역별로는 북미가 2023년 매출을 주도했습니다.

흉막염 치료제 시장 - 세분화 분석 :

세계 흉막염 치료 시장은 진단, 치료법, 투여 형태, 최종 사용자 및 지역에 따라 세분화됩니다.

진단은 혈액 검사, 배양 검사, 엑스레이 검사 등 세 가지로 나뉩니다. 흉막염 치료 시장에서 혈액 검사는 가장 중요한 진단 부문입니다. 이 우위는 흉막염의 일반적인 원인인 근본적인 바이러스 또는 세균 감염을 식별할 수 있기 때문입니다. 혈액검사는 염증과 감염의 표지를 확인할 수 있어 흉막염을 진단하고 다른 유사 질환과 감별하는 데 매우 중요합니다. 배양 검사나 엑스레이 검사도 사용되지만, 혈액 검사는 보다 즉각적인 통찰력을 제공하기 때문에 진단 과정의 핵심적인 역할을 하며 적절한 치료 전략을 안내합니다.

시장은 치료법에 따라 진통제와 진통제, 면역글로불린의 두 가지 범주로 나뉩니다. 진통제와 진통제는 흉막염 치료 시장에서 가장 중요한 치료 부문입니다. 이러한 중요성은 흉막염에 수반되는 심한 통증을 관리하는 데 주요한 역할을 하기 때문에 환자의 고통을 완화하고 삶의 질을 향상시키는 데 필수적입니다. 진통제는 급성 불편함을 효과적으로 처리하고 환자가 더 편안하게 회복 할 수 있도록 도와줍니다. 면역글로불린은 때때로 근본적인 바이러스성 원인을 표적으로 삼기 위해 사용되기도하지만 진통제는 더 널리 사용되고 환자에게 가장 큰 영향을 미치는 증상을 직접적으로 다루기 때문에 치료 옵션의 주류가되었습니다.

흉막염 치료 시장 - 지리적 통찰력

북미에서 흉막염 치료 시장은 인식 개선과 의학 발전으로 인해 눈에 띄게 성장하고 있습니다. 흉막염의 흔한 원인인 바이러스 감염의 유행은 효과적인 치료에 대한 수요를 촉진하고 있습니다. 미국과 캐나다가 시장을 주도하고 있으며, 치료 옵션을 늘리기 위한 연구개발에 많은 관심을 기울이고 있습니다. 잘 구축된 의료 인프라의 존재와 의료비 증가가 시장 확대에 기여하고 있습니다. 또한, 이러한 질병에 취약한 노인 인구 증가는 시장 성장을 더욱 촉진하고 있습니다. 그럼에도 불구하고, 높은 치료 비용과 치료 효과에 대한 보다 종합적인 임상 연구의 필요성이라는 과제는 여전히 남아있습니다.

흉막염 치료제 시장 - 경쟁 구도:

흉막염 치료제 시장의 경쟁 환경은 치료제 개발 및 상용화에 적극적으로 참여하고 있는 여러 주요 기업들이 존재한다는 특징이 있습니다. 제약회사들은 광범위한 조사 역량과 시장 도달 범위를 바탕으로 이 분야에서 두각을 나타내고 있습니다. 베링거인겔하임(Boehringer Ingelheim GmbH)과 아스트라제네카(AstraZeneca plc)도 혁신적인 치료 솔루션에 초점을 맞추고 진단 포트폴리오를 확장하는 중요한 기여자이며, 머크(Merck & Co., Inc.)와 존슨앤드존슨(Johnson & Johnson)은 강력한 치료 옵션을 시장에 제공하는 주요 기업입니다. 를 제공합니다. 또한, Eli Lilly & Company, Sanofi, AbbVie와 같은 기업들은 새로운 치료법 개발 및 전략적 시장 개척에 기여한 것으로 주목받고 있습니다. 이들 기업은 흉막염 환자들의 미충족 수요를 충족시키기 위해 지속적인 연구, 임상시험, 새로운 치료법 채택을 통해 경쟁을 촉진하고 있습니다.

서론
북미
- 개요
- 북미 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석-흉막염 치료 업계

경쟁 대시보드
기업 개요
- Novartis Pharmaceuticals Corporation
- Pfizer Inc.
- GlaxoSmithKline plc
- Boehringer Ingelheim GmbH
- AstraZeneca plc
- Merck &Co., Inc.
- Johnson &Johnson
- Eli Lilly and Company
- Sanofi
- AbbVie Inc.
- Roche Holding AG
- Takeda Pharmaceutical Company Limited
- Mylan NV
- Amgen Inc.
- Bristol-Myers Squibb Company

제13장 애널리스트의 전방위 전망

LSH 24.10.25

REPORT HIGHLIGHT

The Pleurodynia Treatment Market size was valued at USD 130.90 Million in 2023, expanding at a CAGR of 5.90% from 2024 to 2032.

Pleurodynia is a condition characterized by sharp, stabbing pain in the chest due to inflammation of the pleura, the membrane surrounding the lungs. It often results from viral infections, such as those caused by the Coxsackievirus. Treatment typically focuses on relieving pain and addressing the underlying cause. Over-the-counter pain relievers like ibuprofen or acetaminophen are commonly used, alongside rest and sometimes corticosteroids for more severe cases. The market for pleurodynia treatment includes pharmaceutical companies developing pain management medications and diagnostic tools, as well as healthcare providers offering tailored treatment plans.

Pleurodynia Treatment Market- Market Dynamics

Rising incidence of pleurodynia cases due to increased viral infections.

Pleurodynia, often caused by viral infections such as coxsackievirus, has seen a rise in cases due to an increase in viral infections. This trend is reflected in the Pleurodynia Treatment market, which is growing as more cases are diagnosed and managed. Viral infections, particularly those prevalent in colder seasons, contribute to the increased incidence of pleurodynia.

The World Health Organization (WHO) provides relevant data through its Global Health Estimates. According to their 2021 report, viral infections, including those causing pleurodynia, have seen a significant increase over the past decade. Specifically, the incidence of viral infections causing respiratory symptoms, including pleurodynia, rose by approximately 20% between 2010 and 2020. This rise in cases emphasizes the growing need for effective treatments and interventions, driving the pleurodynia treatment market's expansion.

Pleurodynia Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2024-2032)

Based on Diagnosis type segmentation, Blood tests was predicted to show maximum market share in the year 2023

Based on Treatment segmentation, Analgesics, and pain killers was the leading type in 2023

Based on Mode of Administration segmentation, Oral Medicines was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Pleurodynia Treatment Market- Segmentation Analysis:

The Global Pleurodynia Treatment Market is segmented on the basis of Diagnosis, Treatment, Mode of Administration, End-User, and Region.

The market is divided into three categories based on Diagnosis type Blood test, culture test, and X-ray. In the pleurodynia treatment market, blood tests are the most significant diagnostic segment. This prominence is due to their ability to identify underlying viral or bacterial infections that commonly cause pleurodynia. Blood tests can reveal markers of inflammation and infection, which are crucial for diagnosing and differentiating pleurodynia from other similar conditions. While culture tests and X-rays are also used, blood tests provide more immediate and actionable insights, making them central to the diagnostic process and guiding appropriate treatment strategies.

The market is divided into two categories based on Treatment Analgesics or Painkillers Immunoglobulin In the pleurodynia treatment market, analgesics or painkillers are the most significant treatment segment. This prominence stems from their primary role in managing the severe pain associated with pleurodynia, which is essential for patient relief and quality of life. Analgesics address the acute discomfort effectively, allowing patients to recover more comfortably. While immunoglobulins may be used to target underlying viral causes, analgesics are more widely utilized and directly address the symptom that most affects patients, making them the dominant treatment option.

Pleurodynia Treatment Market- Geographical Insights

In North America, the pleurodynia treatment market is experiencing notable growth due to increasing awareness and advancements in medicine. The prevalence of viral infections, which are a common cause of pleurodynia, is driving demand for effective treatments. The United States and Canada lead the market, with a high focus on research and development to enhance treatment options. The presence of established healthcare infrastructure and the rise in healthcare expenditure contribute to market expansion. Moreover, the growing geriatric population, which is more susceptible to such conditions, further fuels market growth. Despite this, challenges such as high treatment costs and the need for more comprehensive clinical studies on treatment efficacy remain.

Pleurodynia Treatment Market- Competitive Landscape:

The competitive landscape of the pleurodynia treatment market is characterized by the presence of several key players who are actively involved in the development and commercialization of therapies. Major pharmaceutical companies like Novartis Pharmaceuticals Corporation, Pfizer Inc., and GlaxoSmithKline plc are prominent in this space, leveraging their extensive research capabilities and market reach. Boehringer Ingelheim GmbH and AstraZeneca plc are also significant contributors, focusing on innovative treatment solutions and expanding their Diagnosis portfolios. Merck & Co., Inc. and Johnson & Johnson are key players that bring robust therapeutic options to the market. Additionally, companies such as Eli Lilly and Company, Sanofi, and AbbVie Inc. are notable for their contributions to the development of new treatments and strategic market positioning. These companies drive competition through ongoing research, clinical trials, and the introduction of novel therapies, aiming to address the unmet needs of patients with pleurodynia.

Recent Developments:

In January 2023, in an article on verywellhealth, an online award-winning resource that offers reliable and factual information on a range of health-related topics, patients can manage their pleurodynia-related pain with nonsteroidal anti-inflammatory drugs such as ibuprofen (Advil), even though there isn't a specific treatment for the condition. Additionally, they proposed that applying warm packs to the afflicted area might also aid in pain relief.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PLEURODYNIA TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Novartis Pharmaceuticals Corporation
Pfizer Inc.
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
AstraZeneca plc
Merck & Co., Inc.
Johnson & Johnson
Eli Lilly and Company
Sanofi
AbbVie Inc.
Roche Holding AG
Takeda Pharmaceutical Company Limited
Mylan N.V.
Amgen Inc.
Bristol-Myers Squibb Company

GLOBAL PLEURODYNIA TREATMENT MARKET, BY DIAGNOSIS TYPE- MARKET ANALYSIS, 2019 - 2032

Blood test
Culture test
X-ray

GLOBAL PLEURODYNIA TREATMENT MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032

Analgesics or Painkillers
Immunoglobulin

GLOBAL PLEURODYNIA TREATMENT MARKET, BY MODE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

Oral
Injections or infusion

GLOBAL PLEURODYNIA TREATMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Pharmacy
Others

GLOBAL PLEURODYNIA TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Pleurodynia Treatment Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Pleurodynia Treatment Market Snippet by Diagnosis
- 2.1.2. Pleurodynia Treatment Market Snippet by Treatment
- 2.1.3. Pleurodynia Treatment Market Snippet by Mode of Administration
- 2.1.4. Pleurodynia Treatment Market Snippet by Technology
- 2.1.5. Pleurodynia Treatment Market Snippet by Country
- 2.1.6. Pleurodynia Treatment Market Snippet by Region
2.2. Competitive Insights

3. Pleurodynia Treatment Key Market Trends

3.1. Pleurodynia Treatment Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Pleurodynia Treatment Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Pleurodynia Treatment Market Opportunities
3.4. Pleurodynia Treatment Market Future Trends

4. Pleurodynia Treatment Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Pleurodynia Treatment Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Pleurodynia Treatment Market Landscape

6.1. Pleurodynia Treatment Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Pleurodynia Treatment Market - By Diagnosis

7.1. Overview
- 7.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
- 7.1.2. Blood test
- 7.1.3. Culture test
- 7.1.4. X-ray

8. Pleurodynia Treatment Market - By Treatment

8.1. Overview
- 8.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
- 8.1.2. Analgesics or Painkillers
- 8.1.3. Immunoglobulin

9. Pleurodynia Treatment Market - By Mode of Administration

9.1. Overview
- 9.1.1. Segment Share Analysis, By Mode of Administration, 2023 & 2032 (%)
- 9.1.2. Oral
- 9.1.3. Injections or infusion

10. Pleurodynia Treatment Market - By End Users

10.1. Overview
- 10.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
- 10.1.2. Hospitals
- 10.1.3. Pharmacy
- 10.1.4. Others

11. Pleurodynia Treatment Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Pleurodynia Treatment Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Pleurodynia Treatment Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.9. Italy
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.3.9.4. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.3.9.5. Italy Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.3.9.6. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.10. United Kingdom
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.3.10.4. United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.3.10.5. United Kingdom Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.3.10.6. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.11. France
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.3.11.4. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.3.11.5. France Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.3.11.6. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.12. Russia
  - 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.2. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.3.12.3. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Russia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.13. Netherlands
  - 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.3.13.3. Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.3.13.4. Netherlands Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.3.13.5. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.15. Poland
  - 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.3.15.3. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Poland Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.16. Rest of Europe
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Rest of the Europe Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Pleurodynia Treatment Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.8. India
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.4.8.4. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.4.8.5. India Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.4.8.6. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.9. China
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.4.9.4. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.4.9.5. China Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.4.9.6. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.13. Thailand
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Thailand Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.14. Indonesia
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Indonesia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Pleurodynia Treatment Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Pleurodynia Treatment Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Pleurodynia Treatment Industry

12.1. Competitive Dashboard
12.2. Company Profiles
- 12.2.1. Novartis Pharmaceuticals Corporation
- 12.2.2. Pfizer Inc.
- 12.2.3. GlaxoSmithKline plc
- 12.2.4. Boehringer Ingelheim GmbH
- 12.2.5. AstraZeneca plc
- 12.2.6. Merck & Co., Inc.
- 12.2.7. Johnson & Johnson
- 12.2.8. Eli Lilly and Company
- 12.2.9. Sanofi
- 12.2.10. AbbVie Inc.
- 12.2.11. Roche Holding AG
- 12.2.12. Takeda Pharmaceutical Company Limited
- 12.2.13. Mylan N.V.
- 12.2.14. Amgen Inc.
- 12.2.15. Bristol-Myers Squibb Company

13. 360 Degree Analyst View

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us